Pharmaceuticals

Andexxa (Ondexxya) Market Forecast Through 2030 With Insights On Market Patterns And Developments

May 5, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Andexxa (Ondexxya) Market During 2026–2030?

Historical period growth was propelled by the extensive utilization of factor xa inhibitors, the occurrence of emergency bleeding incidents, the regulatory endorsement of reversal agents, the escalating need for hospital critical care, and the increasing aging population.

The projected growth is connected to the increasing prevalence of cardiovascular diseases, a greater volume of anticoagulant prescriptions, the expansion of trauma care, improved emergency protocols, and a rise in surgical interventions. Key trends for the forecast period are anticipated to involve a growing need for anticoagulant reversal, developments in emergency bleeding management, the focus on hospital-based critical care therapies, increased adoption of factor Xa inhibitors, and a concentrated effort on rapid hemostasis solutions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19972&type=smp

What Key Drivers Are Fueling The Growth Of The Andexxa (Ondexxya) Market?

The rise in bleeding disorders is anticipated to boost the andexxa (ondexxya) market’s expansion moving forward. Bleeding disorders are a category of medical conditions where blood fails to clot properly, leading to excessive or prolonged blood loss. This increase can be attributed to better diagnosis, heightened awareness, genetic factors, and an aging demographic, all of which contribute to more frequent recognition and detection of these conditions. Andexxa (Ondexxya) is vital for bleeding disorders as it rapidly counteracts the anticoagulant effects of factor Xa inhibitors, thereby preventing life-threatening hemorrhage in urgent situations. For instance, the National Blood Authority, an Australia-based blood management agency, reported in July 2025 that 2,797 patients were living with von Willebrand disease (VWD) in 2023–2024, an increase from 2,669 patients in 2022–2023. Consequently, the growing prevalence of bleeding disorders is fueling the growth of the andexxa (ondexxya) market. The expanding geriatric population is projected to drive the growth of the andexxa (ondexxya) market in the coming years. The geriatric population comprises individuals aged 65 and above, who frequently experience age-related health issues such as chronic illnesses, cognitive decline, and mobility challenges. This demographic is expanding globally due to longer life expectancies and advancements in healthcare. Andexxa (Ondexxya) proves beneficial for the geriatric population by helping to reverse bleeding induced by blood thinners, which older adults are more prone to using for conditions like atrial fibrillation. For example, a report published in October 2022 by the World Health Organization (WHO), a Switzerland-based agency focused on international public health, indicates that one in six people globally is expected to be 60 or older by 2030. Furthermore, by 2050, the worldwide population of individuals aged 60 or more will reach 2.1 billion. Thus, the increasing geriatric population is a key factor propelling the growth of the andexxa (ondexxya) market.

How Is The Andexxa (Ondexxya) Market Broken Down By Segment Categories?

The andexxa (ondexxya) market covered in this report is segmented –

1) By Indication: Reversal Of Bleeding Caused By Factor Xa Inhibitors, Acute Major Bleeding Events, Emergency Surgery Or Procedures

2) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies

3) By End User: Adult, Geriatric, Pediatric

What Trends Are Shaping The Future Of The Andexxa (Ondexxya) Market?

Leading companies within the Andexxa market are concentrating on developing sophisticated anticoagulant reversal treatments to improve patient safety during critical bleeding episodes. This type of therapy represents a targeted intervention designed to neutralize the effects of anticoagulant drugs, thereby rapidly restoring normal clotting function and mitigating the risk of fatal bleeding. For example, in January 2024, AstraZeneca India obtained CDSCO approval to import and commercialize andexanet alfa for severe or refractory bleeding induced by Factor Xa inhibitors like apixaban and rivaroxaban. This recently approved treatment regimen involves an initial intravenous bolus administered over 15–30 minutes, followed by a subsequent 2-hour infusion. Clinical studies of major bleeding have demonstrated the efficacy and safety of andexanet alfa; it enables the early reintroduction of anticoagulation following an event, is generally well-tolerated, and addresses a significant unmet need for patients undergoing treatment with novel oral anticoagulants.

Which Players Are Present In The Andexxa (Ondexxya) Market Space?

Major companies operating in the andexxa (ondexxya) market are AstraZeneca Plc

Get The Full Andexxa (Ondexxya) Market Report:

https://www.thebusinessresearchcompany.com/report/andexxa-ondexxya-global-market-report

Which Geographic Region Dominates The Andexxa (Ondexxya) Market?

North America was the largest region in the andexxa (ondexxya) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the andexxa (ondexxya) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Andexxa (Ondexxya) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/andexxa-ondexxya-global-market-report

Browse Through More Reports Similar to the Global Andexxa (Ondexxya) Market 2026, By The Business Research Company

Hexane Market Report 2026

https://www.thebusinessresearchcompany.com/report/hexane-global-market-report

Esg Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/esg-finance-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795